Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population

Environmental Health Perspectives

Volumn 120, Issue 7, 2012, Pages 1017-1022

  Tellez Plaza, Maria ^a,b   Navas Acien, Ana ^a,c   Menke, Andy ^a   Crainiceanu, Ciprian M ^a   Pastor Barriuso, Roberto ^d,e   Guallar, Eliseo ^a,b,c,f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CARLOS III INSTITUTE OF HEALTH   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cadmium; Cardiovascular disease; Mortality; NHANES; Survey

Indexed keywords

CADMIUM;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG URINE LEVEL; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; ISCHEMIC HEART DISEASE; LIMIT OF DETECTION; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; CADMIUM; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84864121228     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104352     Document Type: Article

References (42)

1. ATSDR (Agency for Toxic Substances and Disease Registry). 2008. Toxicological Profile for Cadmium. Available: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=48&tid=15 [accessed 7June 2011].
2. Bell SG, Vallee BL. 2009. The metal othionein/thionein system: an oxidoreductive metabolic zinc link. Chembiochem 10(1):55-62.
3. Benichou J. 2001. A review of adjusted estimators of attributable risk. Stat Methods Med Res 10(3):195-216.
4. Benowitz NL, Hukkanen J, Jacob P III. 2009. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 192:29-60.
5. Bilgen I, Oner G, Edremitlioglu M, Alkan Z, Cirrik S. 2003. Involvement of cholinoceptors in cadmium-induced endothelial dysfunction. J Basic Clin Physiol Pharmacol 14(1):55-76.
6. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. 1985. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 122(5):904-914.
7. Department of Health and Human Services. 2010. How Tobacco Smoke Causes Disease. The Biology and Behavioral Basis for Smoking-Attributable Diseases. A Report of the Surgeon General. Atlanta, GA:Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
8. 2max in white, black and Mexican Americans. Environ Res 109(3):292-300.
9. Everett CJ, Frithsen IL. 2008. Association of urinary cadmium and myocardial infarction. Environ Res 106(2):284-286.
10. Gallagher CM, Chen JJ, Kovach JS. 2010. Environmental cadmium and breast cancer risk. Aging (Albany NY) 2(11):804-814.
11. Gallagher CM, Kovach JS, Meliker JR. 2008. Urinary cadmium and osteoporosis in U.S. women ≥ 50 years of age: NHANES 1988-1994 and 1999-2004. Environ Health Perspect 116:1338-1343.
12. Grambsch P, Therneau T. 1994. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81(3):515-526.
13. Järup L, Rogenfelt A, Elinder CG, Nogawa K, Kjellström T. 1983. Biological half-time of cadmium in the blood of workers after cessation of exposure. Scand J Work Environ Health 9(4):327-331.
14. Jiang G, Xu L, Song S, Zhu C, Wu Q, Zhang L, et al. 2008. Effects of long-term low-dose cadmium exposure on genomic DNA methylation in human embryo lung fibroblast cells. Toxicology 244(1):49-55.
15. Jin T, Lu J, Nordberg M. 1998. Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metal othionein. Neurotoxicology 19(4-5):529-535.
16. Lee MS, Park SK, Hu H, Lee S. 2011. Cadmium exposure and cardiovascular disease in the 2005 Korea National Health and Nutrition Examination Survey. Environ Res 111(1):171-176.
17. Lumley T. 2004. Analysis of complex survey samples. J Stat Software 9(8):1-19.
18. Maret W. 2009. Molecular aspects of human cellular zinc homeostasis: redox control of zinc potentials and zinc signals. BioMetal. 22(1):149-157.
19. Menke A, Muntner P, Silbergeld EK, Platz EA, Guallar E. 2009. Cadmium levels in urine and mortality among U.S. adults. Environ Health Perspect 117:190-196.
20. Messner B, Knoflach M, Seubert A, Ritsch A, Pfaller K, Henderson B, et al. 2009. Cadmium Is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol 29(9):1392-1398.
21. Nakagawa H, Nishijo M, Morikawa Y, Miura K, Tawara K, Kuriwaki J, et al. 2006. Urinary cadmium and mortality among inhabitants of a cadmium-polluted area in Japan. Environ Res 100(3):323-329.
22. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. 2004. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109(25):3196-3201.
23. Navas-Acien A, Silbergeld EK, Sharrett R, Calderon-Aranda E, Selvin E, Guallar E. 2005. Metal. in urine and peripheral arterial disease. Environ Health Perspect 113:164-169.
24. Navas-Acien A, Tellez-Plaza M, Guallar E, Muntner P, Silbergeld E, Jaar B, et al. 2009. Blood cadmium and lead and chronic kidney disease in U.S. adults: a joint analysis. Am J Epidemiol 170(9):1156-1164.
25. Nawrot TS, Van Hecke E, Thijs L, Richart T, Kuznetsova T, Jin Y, et al. 2008. Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population. Environ Health Perspect 116:1620-1628.
26. NCHS (National Center for Health Statistics). 2008. National Health and Nutrition Examination Surveys. Available: http://www.cdc.gov/nchs/nhanes.htm [accessed 7June 2011].
27. NCHS (National Center for Health Statistics). 2010. NHANES (1999-2004) Linked Mortality Files: Public-Use Data Release. Available: http://www.cdc.gov/nchs/data_access/data_linkage/mortality/nhanes_99_04_ linkage.htm [accessed 7June 2011].
28. Nordberg GF, Nogawa K, Nordberg M, Friberg L. 2007. Cadmium. In: Handbook on the Toxicology of Metal. (Nordberg GF, Fowler BF, Nordberg M, Friberg L, eds). Amsterdam:Elsevier, 445-486.
29. Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. 2010. Cadmium exposure in association with history of stroke and heart failure. Environ Res 110(2):199-206.
30. Prozialeck WC, Edwards JR, Nebert DW, Woods JM, Barchowsky A, Atchison WD. 2008. The vascular system as a target of metal. toxicity. Toxicol Sci 102(2):207-218.
31. R Development Core Team. 2011. R: A Language and Environment for Statistical Computing. Available: http://www.R-project.org [accessed 7June 2011].
32. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, BrownTM, et al. 2011. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123(4):e18-e209.
33. Satarug S, Nishijo M, Lasker JM, Edwards RJ, Moore MR. 2006. Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases? Tohoku J Exp Med 208(3):179-202.
34. Selvin E, Manzi J, Stevens LA, Van Lente F, Lacher DA, Levey AS, et al. 2007. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 50(6):918-926.
35. Stoica A, Katzenellenbogen BS, Martin MB. 2000. Activation of estrogen receptor-alpha by the heavy metal. cadmium. Mol Endocrinol 14(4):545-553.
36. Takiguchi M, Achanzar WE, Qu W, Li G, Waalkes MP. 2003. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res 286(2):355-365.
37. Tellez-Plaza M, Navas-Acien A, Caldwell KL, Menke A, Muntner P, Guallar E. 2012. Reduction in cadmium exposure in the United States population, 1988-2008: the contribution of declining smoking rates. Environ Health Perspect 120:204-209.
38. Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Guallar E. 2008. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect 116:51-56.
39. Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, SharrettAR, Guallar E. 2010. Cadmium and peripheral arterial disease: gender differences in the 1999-2004 U.S. National Health and Nutrition Examination Survey. Am J Epidemiol 172(6):671-681.
40. Valko M, Morris H, Cronin MT. 2005. Metal., toxicity and oxidative stress. Curr Med Chem 12(10):1161-1208.
41. Varoni MV, Palomba D, Satta M, Satta A, Anania V. 2003. Different response of intracerebroventricular cadmium administration on blood pressure in normal and low urinary kallikrein rats. Pharmacol Res 47(2):157-162.
42. World Health Organization. 2007. International Classification of Diseases (ICD-10). Available: http://www.who.int/classifications/icd/en/ [accessed 7June 2011].